VUF 8514
Latest Information Update: 14 Apr 1997
At a glance
- Originator Florida Institute of Technology
- Class Antibacterials; Antifungals; Antituberculars
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycobacterium avium complex infections; Tuberculosis
Most Recent Events
- 14 Apr 1997 No-Development-Reported for Mycobacterium avium complex infections in USA (Unknown route)
- 14 Apr 1997 No-Development-Reported for Tuberculosis in USA (Unknown route)
- 11 May 1995 Preclinical development for Mycobacterium avium complex infections in USA (Unknown route)